Superiority of dendritic cell vaccine vs tumor cell vaccine: survival by stratification subsets in MACVAC randomized Phase II trial of patient-specific vaccines utilizing antigens from autologous melanoma tumor cell lines

Detalles Bibliográficos
Autores principales: Dillman, Robert O, McClay, Edward, Amatruda, Thomas, Semeniuk, George, Haskins, Clark, Weber, Robert, Burtzo, David, DePriest, Carol, Carbonell, Denysha, Cornforth, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649581/
http://dx.doi.org/10.1186/2051-1426-3-S2-P202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649581/
http://dx.doi.org/10.1186/2051-1426-3-S2-P202

Ejemplares similares